Intranasal midazolam

ApprovedSmall molecule

NNourhan M.Aly

Intranasal midazolam is one of 68 small molecule programs targeting Abscess. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

AbscessActive, not recruiting

DeliriumActive, not recruiting

AbscessApproved

Active, not recruiting

DeliriumApproved

Active, not recruiting

Competition

Competitive Landscape

167 competitors in Delirium

#DrugCompanyPhaseTrials

Provigil

NNuvo Research GmbH

Phase 3

1 2

Neurontin

VViatris Specialty LLC

Phase 3

1 3

Luvox

SSolvay Pharmaceuticals

Phase 3

1 4

Intranasal midazolam

NNourhan M.Aly

Approved

1 5

Lidocaine IV

KKasr El Aini Hospital

Phase 3

1 6

Physostigmine

AstraZeneca

Phase 3

1 7

Rozerem

Takeda

Preclinical

6 8

Inapsine

Alnylam Pharmaceuticals

Preclinical

1 9

Anerem

AAcacia Pharma Ltd

Preclinical

7 10

Spravato

WWim Janssens

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Midazolam4 trials

Buccal Versus Intranasal Route of Administration of Midazolam Spray in Behavior Management of Pre-School Patients

Completed·NNourhan M.Aly·Phase 2·NCT04608734·36 enrolled

Volumes of Administration for Intranasal Midazolam

Completed·—·Phase 2·NCT01948908·99 enrolled

Nebulized Lidocaine and Intranasal Midazolam for NGT Insertion in Children

Unknown status·HHamad Medical Corporation·Phase 3·NCT04571879·48 enrolled

Show 1 more trial

AGItated Patients Management: intraNASAL Midazolam vs Intramuscular Loxapine

Terminated·AAssistance Publique - Hôpitaux de Paris·Phase 3·NCT05324852·1 enrolled

Dexmedetomidine2 trials

IN Midazolam vs IN Dexmedetomidine vs IN Ketamine During Minimal Procedures in Pediatric ED

Recruiting·UUniversity of Oklahoma·Phase 4·NCT05934669·90 enrolled

Safety & Efficacy of Intranasal Dexmedetomidine, Fentanyl & Midazolam in the Pediatric Emergency Room

Withdrawn·NNationwide Children's Hospital·Phase 2·NCT05057689

Sedation2 trials

Midazolam and Ketamine Effect Administered Through the Nose for Sedation of Children for Dental Treatment

Completed·UUniversidade Federal de Goias·Phase 4·NCT02447289·84 enrolled

Dose-Finding Study of Intranasal Midazolam for Procedural Sedation in Children

Completed·—·Phase 1/2·NCT04586504·101 enrolled

Randomized Controlled Trial1 trial

Randomized Controlled Trial of Intranasal Ketamine vs. Intranasal Midazolam in Individuals With OCD

Terminated·NNew York State Psychiatric Institute·Phase 2·NCT02206776·2 enrolled

Abscess1 trial

IN Ketamine Vs IN Midazolam and Fentanyl for Abscess I&D

Completed·UUniversity of Tennessee·Phase 4·NCT02635282·19 enrolled

3 more indications

Delirium1 trial

Intranasal Dexmedetomidine Versus Intranasal Midazolam for Emergence Delirium Prevention

Completed·IIndonesia University·Phase 4·NCT04263844·66 enrolled

Laceration1 trial

Intranasal Fentanyl in Combination With Midazolam Versus Midazolam Alone for Pediatric Facial Laceration Repair

Unknown status·UUniversity of Texas at Austin·N/A·NCT04745260·100 enrolled

Treatment1 trial

Intranasal Versus Nebulized Midazolam in Behaviuor Modification of Preschool Children Undergoing Dental Treatment

Completed·NNourhan M.Aly·Phase 2/3·NCT05883150·68 enrolled

Sources

References

[1]
ClinicalTrials.gov — 13 trial records for Intranasal midazolam. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Intranasal midazolam compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Intranasal midazolam. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Nourhan M.Aly company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: NNourhan M.Aly

Intranasal midazolam

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Midazolam4 trials

Dexmedetomidine2 trials

Sedation2 trials

Randomized Controlled Trial1 trial

Abscess1 trial

Delirium1 trial

Laceration1 trial

Treatment1 trial

References

Drug Info

Quick Facts

Related News